Clinical features of sporadic multigland parathyroid disease
https://doi.org/10.29413/ABS.2022-7.6.26
Abstract
Background. Sporadic multigland parathyroid disease (MGD) account for 1/4 of all cases of primary hyperparathyroidism (PHPT). There are no specific signs of MGD in comparison with single-gland parathyroid disease in PHPT. The only radical treatment is surgical, therefore, determining the number of excessively functioning parathyroid glands at the preoperative stage is important for choosing the extent of the operation and the success of the treatment in general.
The aim. To identify the specific signs of multigland parathyroid disease in patients who underwent surgery for primary hyperparathyroidism.
Methods. We conducted a single-center prospective study including 126 cases of surgical treatment of PHPT from December 2019 to June 2021. The study included an analysis of demographic, clinical, laboratory parameters and visual methods of topical diagnosis of parathyroid glands (ultrasound, scintigraphy, multislice computed tomography). The main endpoint of the study was the identification of characteristic signs of MGD in patients with PHPT.
Results. Lower values of creatinine (p ≤ 0.01; Mann – Whitney U-test), albuminadjusted calcium (p ≤ 0.05; Mann – Whitney U-test), parathyroid hormone (p ≤ 0.01; Mann – Whitney U-test), glomerular filtration rate (p ≤ 0.01; Mann – Whitney U-test) and inconsistency of two methods of preoperative imaging (p ≤ 0.01; χ2) were set as specific signs of multigland compared with single-gland parathyroid disease.
Conclusion. The results of preoperative biochemical and imaging studies can become the basis for differentiating single-gland and multigland parathyroid disease in primary hyperparathyroidism.
About the Authors
E. A. Ilyicheva
Irkutsk Scientific Centre of Surgery and Traumatology
Russian Federation
Russian Federation
Elena A. Ilyicheva – Dr. Sc. (Med.), Professor, Head of the Research Department of Clinical Surgery
Bortsov Revolyutsii str., 1, Irkutsk 664003, Russian Federation
G. A. Bersenev
Irkutsk Scientific Centre of Surgery and Traumatology
Russian Federation
Russian Federation
Gleb A. Bersenev – Postgraduate at the Research Department of Clinical Surgery
Bortsov Revolyutsii str., 1, Irkutsk 664003, Russian Federation
References
1. Barczyński M, Bränström R, Dionigi G, Mihai R. Sporadic multiple parathyroid gland disease – a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg. 2015; 400: 887-905. doi: 10.1007/s00423-015-1348-1
2. Kowalski G, Buła G, Bednarczyk A, Gawrychowska A, Gawrychowski J. Multiglandular parathyroid disease. Life (Basel). 2022; 12(8): 1286. doi: 10.3390/life12081286
3. Chen H, Wang TS, Yen TW, Doffek K, Krzywda E, Schaefer S, et al. Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. AnnSurg. 2010; 252(4): 691-695. doi: 10.1097/SLA.0b013e3181f698df
4. Udelsman R. Approach to the patient with persistent or recurrent primary hyperparathyroidism. J Clin Endocrinol Metab. 2011; 96(10): 2950-2958. doi: 10.1210/jc.2011-1010
5. Mazotas IG, Yen TWF, Doffek K, Shaker JL, Carr AA, Evans DB, et al. Persistent/recurrent primary hyperparathyroidism: Does the number of abnormal glands play a role? J Surg Res. 2020; 246: 335-341. doi: 10.1016/j.jss.2019.08.007
6. Their M, Daudi S, Bergenfelz A, Almquist M. Predictors of multiglandular disease in primary hyperparathyroidism. Langenbecks Arch Surg. 2018; 403(1): 103‐109. doi: 10.1007/s00423-017-1647-9
7. Lew JI, Solorzano CC, Montano RE, Carneiro-Pla DM, Irvin GL. Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery. 2008; 144: 299-306. doi: 10.1016/j. surg.2008.03.039
8. Miller BS, England BG, Nehs M, Burney RE, Doherty GM, Gauger PG. Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of < 100 pg/mL. Surgery. 2006; 140(6): 883-889; discussion 889-890. doi: 10.1016/j.surg.2006.07.016
9. Mokrysheva NG, Eremkina AK, Mirnaya SS, Krupinova JA, Voronkova IA, Kim IV, et al. The clinical practice guidelines for primary hyperparathyroidism, short version. Problems of Endocrinology. 2021; 67(4): 94-124. (In Russ.). doi: 10.14341/probl12801
10. Buzanakov DM, Sleptsov IV, Semenov AA, Chernikov RA, Dzhumatov TA, Novokshonov KYu, et al. Benefits of bilateral neck exploration in the treatment of primary hyperparathyroidism. The Hospital. 2021; 31(3): 14-19. (In Russ.).
11. Jones DB, Lucas PA, Jones JH, Lucas PA, Wilkins WE. Changes in blood pressure and renal function after parathyroidectomy in primary hyperparathyroidism. Postgrad Med J. 1983; 59: 350-353. doi: 10.1136/pgmj.59.692.350
12. Çalışkan M, Kızılgül M, Beysel S, Uçan B, Akcan F, Takır M, et al. Factors associated with glomerular filtration rate variation in primary hyperparathyroidism after parathyroidectomy. Turk J Med Sci. 2019; 49(1): 295-300. doi: 10.3906/sag-1806-181
13. Kristoffersson A, Backman C, Granqvist K, Järhult J. Pre‐ and postoperative evaluation of renal function with five different tests in patients with primary hyperparathyroidism. J Intern Med. 1990; 227: 317-324. doi: 10.1111/j.1365-2796.1990.tb00166.x
14. Mizobuchi M, Ogata H, Koiwa F. Secondary hyperparathyroidism: Pathogenesis and latest treatment. Ther Apher Dial. 2019; 23(4): 309-318. doi: 10.1111/1744-9987.12772
15. Kebebew E, Hwang J, Reiff E, Duh Q, Clark O. Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: A simple and accurate scoring model. Arch Surg. 2006; 141(8): 777-782. doi: 10.1001/archsurg.141.8.777
Review
For citations:
Ilyicheva E.A., Bersenev G.A. Clinical features of sporadic multigland parathyroid disease. Acta Biomedica Scientifica. 2022;7(6):258-264. (In Russ.) https://doi.org/10.29413/ABS.2022-7.6.26
Views:
534
Email this article 
